News Article | May 24, 2017
With over 27 years' experience, Reza Vahabzadeh has a strong track record in the Consumer sector, having been involved in numerous transactions across the food, beverage, restaurant, and health/personal care industries, for clients including B&G Foods, Henkel, Hostess Brands and Pinnacle Foods. Prior to joining Rothschild, Mr. Vahabzadeh was a Senior Advisor to the Global Consumer Practice at Perella Weinberg Partners in New York, after spending 13 years at Lehman/Barclays as their High Yield Research Analyst covering the Consumer Products sector. He achieved Institutional Investor's #1 ranking in the space for 12 consecutive years. Mr. Vahabzadeh started his career at Bank of America in Los Angeles, and also worked at Transamerica Investment Management, Credit Suisse and Lehman Brothers. He holds a B.S. in Finance and Accounting, Magna Cum Laude from Boston College and an MBA in Finance from UCLA. Siddharth Hariharan joins Rothschild after 13 years at J.P. Morgan, where he was most recently the Executive Director and Head of Emerging Brands. While at J.P. Morgan, Mr. Hariharan developed a niche expertise in the Consumer sector, working on a number of consumer focused debt, equity and M&A transactions. He has advised clients including Fossil, Clorox, Planet Fitness, Nike and Under Armour, among others. Mr. Hariharan received his B.S. degree in Finance from Indiana University. Aashis Mehta comes to Rothschild from Lazard, where he was a member of their Healthcare Group. While at Lazard, Mr. Mehta served as the sole advisor on a number of healthcare M&A, IPO and restructuring transactions, and advised clients including Celerion, Copernicus Group and LabCorp, among others. Before joining Lazard in 2011, he spent seven years in the Healthcare Group at Credit Suisse and three years at Citigroup. Mr. Mehta holds an undergraduate degree from The Wharton School at the University of Pennsylvania. Timothy Hotchandani comes to Rothschild after spending the last seven years at Deutsche Bank, where he was most recently a Managing Director in the firm's Healthcare Group. During his time at Deutsche Bank, Mr. Hotchandani advised on a variety of M&A, debt and equity transactions for clients including Life Technologies, Abbott, Bio-Techne, Danaher, Merck KGaA, Qiagen and Thermo Fisher, among others. Mr. Hotchandani has also worked at Lehman Brothers, Macquarie Capital and Thomas Weisel Partners. He is a member of the Chartered Financial Analyst Institute and holds a B.B.A. in finance and economics, with distinction and Beta Gamma Sigma, from the University of Wisconsin-Madison. "I am excited to expand the depth and breadth of our coverage of the consumer retail landscape with such talented partners as Reza and Sid. Over the past 3 years, our North American franchise has experienced tremendous growth as clients have come to appreciate the differentiated advice and insights that we bring along with the uniquely coordinated reach of our global platform," said Peter "P.J." Moses, Managing Director at Rothschild Global Advisory, who leads the Consumer team in North America. "Jimmy and I look forward to working with all of our new colleagues to continue to grow our business in this market." This news follows the recent announcement that Chris Gaertner has joined Rothschild Global Advisory as the Global Head of Technology, along with Walid Khiari, who joins the firm as a Managing Director on its Technology team. Mr. Gaertner will lead the launch of the firm's new office in the San Francisco Bay Area. About Rothschild & Co Rothschild & Co is a family-controlled and independent business that has been at the centre of the world's financial markets for over 200 years. It is one of the world's largest independent financial advisory groups, employing approximately 3,300 people in over 40 countries around the world. Our integrated global network of trusted professionals provide in-depth market intelligence and effective long-term solutions for our clients in Global Advisory, Private Wealth, Asset Management, and Merchant Banking. Rothschild Global Advisory, a division of the Rothschild & Co Group, designs and executes strategic M&A and financing solutions. It combines the breadth of its advisory offering with a high volume of transactions to achieve a unique understanding and perspective into markets and participants worldwide. Rothschild Global Advisory provides impartial, expert advice to large and mid-sized corporations, private equity, families and entrepreneurs, and governments through an unrivalled network of 900 industry and financing specialists in over 40 countries worldwide. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/rothschild--co-adds-four-managing-directors-to-consumer-and-healthcare-teams-in-the-us-300462549.html
News Article | June 16, 2017
PHILADELPHIA--(BUSINESS WIRE)--Fox Rothschild LLP is pleased to announce that Elizabeth Litten and Mark McCreary, CIPP/US have been named co-chairs of the firm’s national Privacy and Data Security Practice. Recognized as a pioneer in this quickly evolving area of law, Fox has developed several cutting-edge strategies to keep clients and contacts informed on the latest developments in the laws and regulations that govern privacy and data security. Fox’s national network of Privacy and Data Security attorneys frequently speak on the balance between the government’s need to gather information to safeguard national interests and an individual’s right to privacy under the Fourth Amendment. With more than 30 attorneys nationwide, the group was lauded by BTI in its list of Law Firms Best at Cybersecurity. Litten is ranked as a leading health care attorney in New Jersey by Chambers USA. She serves as national and regional counsel to hospital systems, health care facilities, health plans, technology companies, physicians groups and a wide range of other health care-related organizations and entities. McCreary, who was named a Trailblazer in cyber security law by The National Law Journal, focuses his practice on compliance with privacy-related laws and regulations (domestic and international), as well as responses in the event of a data breach. Fox Rothschild LLP (www.foxrothschild.com) is a full-service law firm built to serve businesses of all sizes as well as individuals. Over the past 100 years, we have grown to 800 lawyers in 22 offices coast to coast. Clients come to Fox because we understand their issues, their priorities and the way they think. At Fox, we care about your success as much as you do.
News Article | August 7, 2017
– Bordeaux-based Baron Philippe de Rothschild SA and Shaw Ross International Importers, LLC announce they have entered into an exclusive U.S. import agreement for its French branded wines, Mouton Cadet, the world’s best-selling Bordeaux wine, and the Pays d’Oc varietals. According to both parties, the agreement takes effect as of today, 7th August, 2017. “We are delighted to have entered into this new import agreement with Shaw Ross International. Mouton Cadet features unique style and the finest winemaking skills backed up by Baron Philippe de Rothschild’s history. With its team’s expertise and our shared vision of excellence, we are very confident that Shaw Ross will continue to build the most efficient network of distributors and play a major part in the performance of Mouton Cadet and our French branded wines on the American market”, says Philippe Sereys de Rothschild, Chairman of the Supervisory Board of Baron Philippe de Rothschild. “We are honored to include Baron Philippe de Rothschild’s French brands in our portfolio as we share the same values of quality and innovation,” says Bruce Hunter, Managing Director of Shaw Ross. “Thanks to our diverse and strategic balance of wines from prestigious family companies, and our field of expertise in ensuring the best and most efficient distribution, we are particularly looking forward to taking Mouton Cadet a step further in its US development.” Baron Philippe de Rothschild’s branded wines were previously imported by Constellation Brands USA which will work closely with Shaw Ross to ensure a smooth transition in the months to come. Mouton Cadet was created in 1930 by the legendary Baron Philippe de Rothschild (1902 – 1988). It was first introduced to the American market in the 1950’s with great success. Thanks to Baroness Philippine de Rothschild (1933 – 2014), Mouton Cadet has experienced significant growth thus expanding its international distribution and leadership to 150 markets, becoming the best-selling Bordeaux brand worldwide. Since 1933, the family-owned company Baron Philippe de Rothschild SA, located in the heart of the Pauillac vineyard, has been motivated by a constant ambition: to make the world’s finest wines, each in its own category. That applies both to the châteaux wines for which it is responsible – the renowned Château Mouton Rothschild, a First Growth, Château Clerc Milon and Château d’Armailhac – and to its branded wines, including the famous Mouton Cadet, the world’s best-selling Bordeaux wine. Baron Philippe de Rothschild’s expertise and excellence are also to be found in the Pays d’Oc with Domaine de Baronarques, in California with Opus One, and in Chile with Almaviva. The company also produces branded wines at the Baron Philippe de Rothschild Maipo Chile bodega. For more information go to www.bpdr.com. Founded in 1968 as a wine and spirit importer representing a handful of brands, Shaw Ross has grown into one of the nation’s leading importers representing 35 suppliers from around the world. Shaw Ross continues to evolve its portfolio to keep ahead of the ever-changing wine and spirit industry. For more information go to www.shawross.com.
News Article | May 9, 2017
On the firm's opening of its office in Silicon Valley, Robert Leitão, Managing Partner and Head of Rothschild Global Advisory, said, "We have been serving clients in the San Francisco Bay Area for some time, and the opening of our office there will allow us to strengthen our team, ensuring that our clients continue to have access to the best people and advice. The U.S. and North American markets are a strategic priority for our firm, and this announcement demonstrates our commitment to the region. Following the opening of our Chicago office last year and the success of our team in Los Angeles over the past few years, Silicon Valley is another key piece in our plan to build out the business in the U.S." With nearly 30 years of experience, Mr. Gaertner has significant depth and breadth within the technology sector, most recently with Credit Suisse as Managing Director and Global Head of Corporate Finance Technology Investment Banking. Prior to Credit Suisse, Mr. Gaertner was a Managing Director at Bank of America Merrill Lynch and held roles as Head of Technology Investment Banking and Head of Global Software and Enterprise Technology Investment Banking. He was also previously a Managing Director and Head of Global Software at Lehman Brothers. Over his career, Mr. Gaertner has advised a number of leading technology firms, including Microsoft, Intel, HP, Ansys, Cisco, Oracle, Lyft, Palantir, Dell, Google, Adobe, Apple, IBM and Amazon, among a host of others. Mr. Gaertner holds an MBA from The Wharton School at the University of Pennsylvania, a Master of Science degree in Electrical Engineering from Columbia University, and a Bachelor of Science degree in Electrical Engineering from the U.S. Military Academy at West Point. "Rothschild is a world class firm and I am honored to be joining and leading its Global Technology business," said Mr. Gaertner. "Helping this illustrious firm strengthen its presence in Silicon Valley by opening its new office is an incredible opportunity, and I am eager to help the firm in its commitment to this market. I look forward to working with Walid and my new colleagues to provide our clients with the best advice and services possible." Mr. Khiari joins Rothschild, effective August 7, 2017, after spending 20 years in investment banking. He joins Rothschild from Credit Suisse where he served as Director of Technology Investment Banking. Prior to this, he worked for Bank of America Merrill Lynch in the Technology Investment Banking group. He has worked with clients around the world and spent time early in his career in Tokyo, Japan. His recent transaction experience includes the $4.7 billion sale of Blue Coat Systems to Symantec, the $2 billion acquisition of Websense by Raytheon, and the $1.5 billion sale of Hybris Security to SAP, among others. Mr. Khiari has a deep and broad network across global technology markets, including Australia, Europe, Canada and Silicon Valley. Mr. Khiari holds a Bachelor of Science from the University of Paris and an MBA from The Wharton School. "I am excited about this opportunity to join Chris, who I have worked with for many years, as well as Jimmy and the entire team at Rothschild to found and grow this new office," said Mr. Khiari. "Rothschild has a global reputation for premier client service, and I look forward to delivering that for our clients in the technology sector and here in the San Francisco Bay Area." About Rothschild & Co Rothschild & Co is a family-controlled and independent business that has been at the centre of the world's financial markets for over 200 years. It is one of the world's largest independent financial advisory groups, employing approximately 3,300 people in over 40 countries around the world. Our integrated global network of trusted professionals provide in-depth market intelligence and effective long-term solutions for our clients in Global Advisory, Private Wealth, Asset Management, and Merchant Banking. Rothschild Global Advisory, a division of the Rothschild & Co Group, designs and executes strategic M&A and financing solutions. It combines the breadth of its advisory offering with a high volume of transactions to achieve a unique understanding and perspective into markets and participants worldwide. Rothschild Global Advisory provides impartial, expert advice to large and mid-sized corporations, private equity, families and entrepreneurs, and governments through an unrivalled network of 900 industry and financing specialists in over 40 countries worldwide. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/rothschild--co-hires-chris-gaertner-as-global-head-of-technology-300453674.html
Sahel J.-A.,French Institute of Health and Medical Research |
Sahel J.-A.,University Pierre and Marie Curie |
Sahel J.-A.,French National Center for Scientific Research |
Sahel J.-A.,Rothschild |
Roska B.,Friedrich Miescher Institute for Biomedical Research
Annual Review of Neuroscience | Year: 2013
Sight-restoring therapy for the visually impaired and blind is a major unmet medical need. Ocular gene therapy is a rational choice for restoring vision or preventing the loss of vision because most blinding diseases originate in cellular components of the eye, a compartment that is optimally suited for the delivery of genes, and many of these diseases have a genetic origin or genetic component. In recent years we have witnessed major advances in the field of ocular gene therapy, and proof-of-concept studies are under way to evaluate the safety and efficacy of human gene therapies. Here we discuss the concepts and recent advances in gene therapy in the retina. Our review discusses traditional approaches such as gene replacement and neuroprotection and also new avenues such as optogenetic therapies. We conjecture that advances in gene therapy in the retina will pave the way for gene therapies in other parts of the brain. Copyright ©2013 by Annual Reviews. All rights reserved.
Stroke | Year: 2017
BACKGROUND AND PURPOSE—: The technique of a direct aspiration first pass technique (ADAPT) for the endovascular treatment of stroke has been reported to be fast, safe, and effective for the treatment of acute ischemic stroke. The aim of this study is to determine the preoperative factors that affect success of the aspiration component of the technique in ischemic stroke patients with large vessel occlusion in the anterior circulation. METHODS—: We enrolled all 347 consecutive patients with anterior circulation acute ischemic stroke admitted for mechanical thrombectomy at our institution from August 2013 to October 2015 and treated by ADAPT for the endovascular treatment of stroke. Baseline and procedural characteristics, modified thrombolysis in cerebral infarction scores, and 3-month modified Rankin Scale were captured and analyzed. RESULTS—: Among the 347 patients (occlusion sites: middle cerebral artery=200, 58%; internal carotid artery Siphon=89, 25%; Tandem=58, 17%), aspiration component led to successful reperfusion (modified thrombolysis in cerebral infarction 2b/3 scores) in 55.6% (193/347 patients), stent retrievers were required in 40%, and a total successful final reperfusion rate of 83% (288/347) was achieved. Overall, procedural complications occurred in 13.3% of patients (48/347). Modified Rankin Scale score of 0 to 2 at 90 days was reported in 45% (144/323). Only 2 factors positively influenced the success of the aspiration component: an isolated middle cerebral artery occlusion (P<0.001) and a shorter time from stroke onset to clot contact (P=0.018). CONCLUSIONS—: In this large retrospective study, ADAPT for the endovascular treatment of stroke technique was shown to be safe and effective for anterior circulation acute ischemic stroke with a final successful reperfusion achieved in 83%. The site of arterial occlusion and delay of the procedure were predictors for reperfusion. CLINICAL TRIAL REGISTRATION—: URL: http://www.clinicaltrials.gov. Unique identifier: NCT02523261, NCT02678169, and NCT02466893. © 2017 American Heart Association, Inc.
Investigative Ophthalmology and Visual Science | Year: 2012
Purpose. To investigate the application of anterior corneal and ocular aberrations in detecting mildly ectatic corneas. Methods. This study retrospectively reviewed the data of 220 eyes separated into three groups by the NIDEK Corneal Navigator System automated corneal classification software: normal (N) (n = 123); forme fruste keratoconus (N topography with contralateral KC) (n = 34); and KC (n = 63). Anterior corneal and ocular aberrations were obtained with the optical path difference scan and compared using a Kruskal-Wallis test. Evaluation of these data to discriminate between the three groups was assessed using a Receiver-Operating Characteristic curve analysis. Results. Corneal and ocular tilt, vertical coma, and trefoil were significantly different in the FFKC as compared with the N group. The discriminant functions between the FFKC and the N group, and between the KC and the N group reached an area under the receiver operating characteristic curve of 0.98 and 0, 96, respectively. Conclusion. Indices generated from corneal and ocular wavefront can identify very mild forms of ectasia that may be undetected by Placido-based neural network programs. © 2012 The Association for Research in Vision and Ophthalmology, Inc.
Journal of Physiology Paris | Year: 2013
Sleep is a key element, both physiologically and psychologically, in adolescent development. The prevalence of sleep disorders in western countries is important, as with age the sleep-wake cycle of adolescents becomes irregular and delayed in relation with later sleep onset and waking time resulting in rhythm desynchronization. A large number of adolescents sleep for 7-8. h instead of 9-10. h per night, which can lead to a cumulative sleep debt with fatigue, behavioral problems and poor academic achievement. The effect of electronic media use (such as television, mobile phone, computer, and electronic gaming) on sleep has been the object of several international studies, though pubertal changes may also impact adolescent sleep. Adolescents and their parents should be educated by professionals, including physicians and nurses, on the key role of sleep in adolescent well being and quality of life. A number of basic rules are proposed to improve sleep in adolescents. The permanent social jet lag experienced by a number of adolescents should be considered as a matter of public health. © 2013 Elsevier Ltd.
Des Jarlais D.C.,Rothschild
BMC public health | Year: 2013
Persons who inject drugs (PWID) are at an elevated risk for human immunodeficiency virus (HIV) and hepatitis C virus (HCV) infection. In many high-income countries, needle and syringe exchange programs (NSP) have been associated with reductions in blood-borne infections. However, we do not have a good understanding of the effectiveness of NSP in low/middle-income and transitional-economy countries. A systematic literature review based on PRISMA guidelines was utilized to collect primary study data on coverage of NSP programs and changes in HIV and HCV infection over time among PWID in low-and middle-income and transitional countries (LMICs). Included studies reported laboratory measures of either HIV or HCV and at least 50% coverage of the local injecting population (through direct use or through secondary exchange). We also included national reports on newly reported HIV cases for countries that had national level data for PWID in conjunction with NSP scale-up and implementation. Studies of 11 NSPs with high-coverage from Bangladesh, Brazil, China, Estonia, Iran, Lithuania, Taiwan, Thailand and Vietnam were included in the review. In five studies HIV prevalence decreased (range -3% to -15%) and in three studies HCV prevalence decreased (range -4.2% to -10.2%). In two studies HIV prevalence increased (range +5.6% to +14.8%). HCV incidence remained stable in one study. Of the four national reports of newly reported HIV cases, three reported decreases during NSP expansion, ranging from -30% to -93.3%, while one national report documented an increase in cases (+37.6%). Estimated incidence among new injectors decreased in three studies, with reductions ranging from -11/100 person years at risk to -16/100 person years at risk. While not fully consistent, the data generally support the effectiveness of NSP in reducing HIV and HCV infection in low/middle-income and transitional-economy countries. If high coverage is achieved, NSP appear to be as effective in LMICs as in high-income countries. Additional monitoring and evaluation research is needed for NSPs where reductions in HIV/HCV infection among PWID are not occurring in order to identify and correct contributing problems.
Rothschild | Date: 2016-02-08
Devices, systems and methods for remotely entering, storing and sharing location addresses for a positional information device, e.g., a global positioning system (GPS) device, are provided. The present disclosure allows a user to easily and safely enter an address into a GPS device by giving that address to a remote communications link and to have that link automatically program the users GPS device for usage. The device, system and method of the present disclosure further allows the user to use this stored address(es) on multiple GPS devices without having to manually enter the address(es).